ISIN No
|
INE059A01026
|
BSE Code / NSE Code
|
500087 / CIPLA
|
Book Value (Rs.)
|
289.93
|
Face Value
|
2.00
|
Bookclosure
|
21/07/2023
|
52Week High
|
1284
|
EPS
|
34.71
|
P/E
|
34.64
|
Market Cap.
|
97067.74 Cr.
|
52Week Low
|
852
|
P/BV / Div Yield (%)
|
4.15 / 0.71
|
Market Lot
|
1.00
|
Security Type
|
Other
|
|
You can view the investment break up of the company with details such as Security name, Security type, Company type, investmement cost etc.
YearEnd | Security Name | Security Type | Company Type | Cost of Investments |
2303 |
Cipla (EU) Ltd.
| Equity Share | Subsidiary | 5236.40 |
2303 |
Investment in mutual funds
| Mutual Fund Scheme | Mutual Fund | 2771.44 |
2303 |
Cipla Medpro South Africa (Pty) Ltd.
| Equity Share | Subsidiary | 2081.09 |
2303 |
Cipla Health Ltd.
| Equity Share | Subsidiary | 631.51 |
2303 |
Meditab Specialities Ltd.
| Equity Share | Subsidiary | 382.57 |
2303 |
Goldencross Pharma Ltd.
| Equity Share | Subsidiary | 191.12 |
2303 |
Meditab Specialities Ltd.
| Others | Subsidiary | 107.50 |
2303 |
Jay Precision Pharmaceuticals Pvt. Ltd.
| Equity Share | Subsidiary | 96.24 |
|